Genetic factors in colorectal cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

M. Ma'ruf, L. Irham, W. Adikusuma, M. Mazaya, A. Mubaraq, D. Illian, Arini Sabilah Al Mustaqimah, Linda Chiuman, Hayssam M. Ali, S. S. Al Mustaniroh, Mohammad Basyuni

2026.5.31Journal of Genetic Engineering and Biotechnology

DOI: 10.1016/j.jgeb.2026.100713

Abstract

Colorectal cancer (CRC) is the third most prevalent cancer globally, accounting for 9.6% of newly diagnosed cases and 9.3% of cancer-related deaths. It develops from the uncontrolled proliferation of glandular cells in the colon and rectum and is categorized into three primary types: sporadic, hereditary, and colitis-associated. While genetic susceptibility is a key factor in CRC pathogenesis, identifying high-impact pathogenic variants remains a significant challenge. This study integrates bioinformatics and population genetics approaches to identify CRC-associated single-nucleotide polymorphisms (SNPs) with potential clinical significance. CRC-associated SNPs were extracted from the Genome-Wide Association Studies (GWAS) Catalog, functionally annotated via HaploReg, and validated via Ensembl. In addition, expression quantitative trait locus (eQTL) data from the GTEx database were used to assess the effects of these variants on gene expression across human tissues. Our analysis identified three high-priority SNPs (rs9379084, rs3184504, and rs11557154) associated with the RREB1, ATXN2, SH2B3, and DCAF12 genes, which exhibited marked allele frequency differences among populations. These findings suggest potential biomarkers for CRC risk assessment and highlight the importance of genetic screening across diverse populations.

Citation format

MA'RUF, M., et al. The bioinformatics approach to identifying pathogenic variants for colorectal cancer (CRC). Journal of Genetic Engineering and Biotechnology, 2026, 24(3): 100713.